Index.php

Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical firms, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to do so may possibly be grounds for compensation. Our lawyers are functioning tough to obtain these hurt by the drug the compensation they're entitled to.

Whilst bleeding is actually a widespread complication associated with anticoagulants, it has been alleged that Xarelto is much more harmful than conventional blood thinners because no antidote exists to reverse its blood-thinning effects. This implies that, inside the event of an emergency, patients could be at danger for irreversible bleeding problems, like life-threatening internal and gastrointestinal hemorrhaging.

Should you or perhaps a loved one particular suffered a significant bleeding event after taking Xarelto, you may have legal recourse. For a lot more details, make contact with us nowadays to have your case reviewed, cost-free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in cases of death, funeral costs. Moreover, they're looking for punitive damages, which are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Becoming Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates http://xareltoexpert.bitbucket.org/categories/New-York/Side-Effects-Xarelto-Niagara-Falls-NY-14305.html of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for a lot more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.